Fate Therapeutics's total assets for Q1 2026 were $284.92M, a decrease of -10.67% from the previous quarter. FATE total liabilities were $105.21M for the fiscal quarter, a -5.86% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.